Inhibition of TGF-β3 restores the invasive capability of extravillous trophoblasts in preeclamptic pregnancies

Journal of Clinical Investigation

Volumn 103, Issue 12, 1999, Pages 1641-1650

  Caniggia, Isabella ^a,b   Grisaru Gravnosky, Sorina ^b   Kuliszewsky, Maciej ^b   Post, Martin ^b   Lye, Stephen J ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL INVASION; CELL TYPE; CONTROLLED STUDY; GESTATIONAL AGE; HUMAN; HUMAN CELL; HUMAN TISSUE; PHENOTYPE; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TROPHOBLAST;

EID: 0032746177     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI6380     Document Type: Article

References (48)

1. Cross, J.C., Werb, Z., and Fisher, S.J. 1994. Implantation and the placenta: key pieces of the development puzzle. Science. 266:1508-1518.
2. Strickland, S., and Richards, W.G. 1992. Invasion of trophoblasts. Cell. 71:355-357.
3. Damsky, C.H., Fitzgerald, M.L., and Fisher, S.J. 1992. Distribution patterns of extracellular matrix components and adhesion receptors are intricately modulated during first trimester cytotrophoblast differentiation along the invasive pathway in vivo. J. Clin. Invest. 89:221-222.
4. Aplin, J.D. 1991. Implantation, trophoblast differentiation and haemochorial placentation: mechanistic evidence in vivo and in vitro. J. Cell Sci. 99:681-692.
5. Redman, C.W.G. 1991. Current topic: pre-eclampsia and the placenta. Placenta. 12:301-308.
6. Khong, T.Y., De Wolf, F., Robertson, W.B., and Brosens, I. 1986. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational-age infants. Br. J. Obstet. Gynaecol. 93:1049-1059.
7. Roberts, J.M., Taylor, R.N., Friedman, S.A., and Goldfien, A. 1990. New development in preeclampsia. Fetal Matern. Med. Rev. 2:125-141.
8. Broughton Pipkin, F., and Rubin, P.C. 1994. Pre-eclampsia the "disease of theories." Br Med. Bull. 50:381-396.
9. Pritchard, J.A., and Mc Donald, P.C. 1980. Hypertensive disorders of pregnancy. In Williams' obstetrics. 16th edition. J.A. Pritchard and P.C. McDonald, editors. Appleton-Century-Croft. New York, NY. 665-700.
10. Slattery, M.A., Khong, T.Y., Dawkins, R.R., Pridemore, B.R., and Hague, W.M. 1993. Eclampsia in association with partial molar pregnancy and congenital abnormalities. Am. J. Obstet. Gynecol. 169:1625-1627.
11. Redline, R.W., and Parterson, P. 1995. Pre-eclampsia is associared with an excess of proliferative immature intermediate trophoblast. Hum. Pathol. 26:594-600.
12. Zhou, Y., Damsky, C.H., Chiu, K., Roberts, J.M., and Fisher, S.J. 1993. Preeclampsia is associated with abnormal expression of adhesion molecules by invasive cytotrophoblasts. J. Clin. Invest. 91:950-960.
13. DeGroot, C.J., O'Brien, T.J., and Taylor, R.N. 1996. Biochemical evidence of impaired trophoblastic invasion of decidual stroma in women destined to have preeclampsia. Am. J. Obstet. Gynecol. 175:24-29.
14. Kingdom, J.C.P., and Kaufmann, P. 1997. Current topic: oxygen and placental villous development: origin of fetal hypoxia. Placenta. 18:613-621.
15. Arkwright, P.D., Rademacher, T.W., Dwek, R.A., and Redman, C.W. 1993. Pre-eclampsia is associated with an increase in trophoblast glycogen content and glycogen synthase activity, similar to that found in hydatidiform moles. J. Clin. Invest. 91:2744-2753.
16. Cross, J.C. 1996. Trophoblast function in normal and preeclamptic pregnancy. Fetal Matern. Med. Rev. 8:57-66.
17. Zhou, Y., et al. 1997. Human cytotrophoblasts adopt a vascular phenotype as they differentiate. J. Clin. Invest. 99:2139-2151.
18. Bass, K.E., et al. Human cycotrophoblast invasion is up-regulated by epidermal growth factor: evidence that paracrine factors modify this process. Dev. Biol. 164:550-561.
19. Lala, P., and Lysiak, J. 1994. Role of locally produced growth factors in human placental growth and invasion with special reference to transforming growth factors. In Immunology of Reproduction. J.S. Hunt, editor. Springer-Verlag. New York, NY. 57-81.
20. Irving, J.A., and Lala, P.K. 1995. Functional role of cell surface integrins on human trophoblast cell migration: regulation by TGF-β, IGF-II and IGFBP-1. Exp. Cell Res. 217:419-427.
21. Librach, C.I., et al. 1994. Interleukin-1β regulates human cytotrophoblast metalloproteinase activity and invasion in vitro. J. Biol. Chem. 269:17125-17131.
22. Massague, J., and Weis-Garcia, F. 1996. Serine/threonine kinase receptors: mediators of transforming growth factor beta family signals. Cancer Surv. 27:41-64.
23. Blaydes, J.P., and Wynford-Thomas, D. 1996. Loss of responsiveness to transforming growth factor beta (TGF beta) is tightly linked to tumorigenicity in a model of thyroid tumor progression. Int. J. Cancer. 65:525-530.
24. Wang, J., et al. 1996. Reduced expression of transforming growth factor beta type I receptor contributes to the malignancy of human colon carcinoma cells. J. Biol. Chem. 271:17366-17371.
25. Graham, C.H., and Lala, P.K. Mechanism of control of trophoblast invasion in situ. 1991. J. Cell. Physiol. 148:228-234.
26. Morrish, D.W., Bhardwaj D., and Paras, M.T. 1991. Transforming growth factor β1 inhibits placental differentiation and human chorionic gonadotropin and human placental lactogen secretion. Endocrinology. 129:22-26.
27. Caniggia, I., Lye, S.J.L., and Cross, J.C. 1997. Activin is a local regulator of human cytotrophoblast cell differentiation. Endocrinology. 138:3976-3986.
28. Caniggia, I., Taylor, C.V., Ritchie, J.W.K., Lye, S.J., and Letarte, M. 1997. Endoglin regulates trophoblast differentiation along the invasive pathway in human placental villous explants. Endocrinology. 138:4977-4988.
29. Chesley, L. 1985. Diagnostic criteria of preeclampsia. Obstet. Gynecol. 65:423-425.
30. Genbacev, O., Schubach, S.A., and Miller, R.K. 1992. Villous culture of first trimester human placenta-model to study extravillous trophoblast (EVT) differentiation. Placenta. 13:439-461.
31. Chai, Y., et al. 1994. Specific transforming growth factor-β subtypes regulate embryonic mouse Meckel's cartilage and tooth development. Dev. Biol. 162:85-103.
32. Malcolm, A.D.B. 1992. Uses and applications of antisense oligonucleotides: uses of antisense nucleic acids - an introduction. Biochem. Soc. Trans. 20:745-746.
33. 3.J. Biol. Chem. 270:2722-2728.
34. Braissant, O., and Wahli, W. 1998. A simplified in situ hybridization protocol using non-radioactively labeled probes to detect abundant and rare mRNAs on tissue sections. Biochemica. 1:10-16.
35. Engvall, E., and Ruoslhati, E. 1977. Binding of soluble form of fibroblast surface protein, fibronectin, to collagen. Int. J. Cancer. 20:1-5.
36. Damsky, C.H., et al. 1994. Integrin switching regulates normal trophoblast invasion. Development. 120:3657-3666.
37. Bischof, P., Redard, M., Gindre, P., Vassilakos, P., and Campana, A. 1993. Localization of alpha2, alpha5 and alpha6 integrin subunits in human endometrium, decidua and trophoblast. Eur. J. Obstet. Gynecol. Reprod. Biol. 51:217-226.
38. St.-Jacques, S., Forte, M., Lye, S.J., and Letarte, M. 1994. Localization of endoglin a transforming growth factor-β binding protein, and of CD44 and integrins in placenta during the first trimester of pregnancy. Biol. Reprod. 51:405-413.
39. Bischof, P., Haenggeli, L., and Campana, A. Gelatinase and oncofetal fibronectin secretion is dependent on integrin expression on human cytotrophoblasts. 1995. Hum. Reprod. 10:734-742.
40. Kupferminc, M.J., Peaceman, A.M., Wigton, T.R., Rehnberg, K.A., and Socol, M.A. 1995. Fetal fibronectin levels are elevated in maternal plasma and amniotic fluid of patients with severe preeclampsia . Am. J. Obstet. Gynecol. 172:649-653.
41. Zhou, Y., Damsky, C.H., and Fisher, S.J. 1997. Preeclampsia is associated with failure of human cytotrophoblast to mimic a vascular adhesion phenotype. J. Clin. Invest. 99:2152-2164.
42. Brubaker, D.B., Ross, M.G., and Marinoff, D. 1992. The function of elevated plasma fibronectin in preeclampsia. Am. J. Obstet. Gynecol. 166:526-531.
43. Wang, Y., and Wals, S.W. 1996. TNF alpha concentrations and mRNA expression are increased in preeclamptic placentas. J. Reprod. Immunol. 32:157-169.
44. Hara, N., et al. 1996. Altered expression of human leukocyte antigen G (HLA-G) on extravillous trophoblast in preeclampsia: immunohistological demonstration with anti-HLA-G specific antibody "87G" and anti-cytokeratin antibody "CAM5.2." Am. J. Reprod. Immunol. 36:349-358.
45. Cooper, J.C., Sharkey, A.M., Charnock-Jones, D.S., Palmer, C.R., and Smith, S.K. 1996. VEGF mRNA levels in placentae from pregnancies complicated by pre-eclampsia. Br. J. Obstet. Gynaecol. 103:1191-1196.
46. Hayashi, M., Numaguchi, M., Watabe, H., and Yaoi, Y. 1996. High blood levels of macrophage colony-stimulating factor in preeclampsia. Blood. 88:4426-4428.
47. Graham, C.H., and McCrae, K.R. 1996. Altered expression of gelatinase and surface-associated plasminogen activator activity by trophoblast cells isolated from placentas of preeclamptic patients. Am. J. Obstet. Gynecol. 175:555-562.
48. Giudice, L.C., Martina, N.A., Crystal, R.A., Tazuke, S., and Druzin, M. 1997. Insulin-like growth factor binding protein-1 at the maternal-fetal interface and insulin-like growth factor I, insulin-like growth factor II, and insulin-like growth factor binding protein-1 in the circulation of women with severe preeclampsia. Am. J. Obstet. Gynecol. 176:751-757.